• LAST PRICE
    11.8000
  • TODAY'S CHANGE (%)
    Trending Up0.7800 (7.0780%)
  • Bid / Lots
    11.5200/ 4
  • Ask / Lots
    12.3100/ 1
  • Open / Previous Close
    11.1100 / 11.0200
  • Day Range
    Low 11.1100
    High 11.8500
  • 52 Week Range
    Low 7.4000
    High 13.9650
  • Volume
    328,325
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 11.02
TimeVolumeCARA
09:32 ET99111.1138
09:35 ET99211.415
09:37 ET30011.44
09:39 ET10011.44
09:42 ET31711.37
09:44 ET20011.32
09:46 ET50011.275
09:50 ET24511.35
09:53 ET10011.31
10:02 ET40011.31
10:06 ET89111.29
10:08 ET50911.2861
10:09 ET142711.29
10:11 ET350011.34
10:15 ET10011.29
10:18 ET161411.29
10:20 ET10011.275
10:26 ET70011.27
10:31 ET70711.3
10:36 ET10011.33
10:38 ET64011.36
10:44 ET53511.43
10:45 ET60011.37
10:47 ET10011.38
10:49 ET110011.4181
10:58 ET130011.3801
11:00 ET10011.4
11:02 ET30011.42
11:03 ET70011.42
11:05 ET114711.42
11:07 ET80011.46
11:12 ET415311.47
11:16 ET30011.48
11:18 ET10011.485
11:20 ET20011.47
11:21 ET140311.49
11:23 ET10011.47
11:27 ET72111.46
11:30 ET115811.44
11:32 ET30011.45
11:34 ET23411.468
11:36 ET220011.49
11:38 ET75911.5
11:41 ET120011.505
11:43 ET465711.49
11:45 ET10011.515
11:48 ET10011.51
11:54 ET101511.495
11:56 ET30011.46
11:59 ET20011.46
12:01 ET10011.46
12:06 ET20011.46
12:08 ET11711.4395
12:12 ET83111.43
12:14 ET30011.425
12:21 ET70011.428
12:24 ET195111.47
12:26 ET70011.46
12:33 ET20011.475
12:37 ET61411.445
12:39 ET40311.43
12:42 ET20011.41
12:44 ET10011.4
12:48 ET80011.44
12:50 ET230011.4
12:51 ET335011.355
12:53 ET40011.37
12:55 ET110511.4
12:57 ET30011.405
01:00 ET48611.4
01:02 ET20011.4
01:06 ET30011.425
01:08 ET10011.43
01:09 ET60011.425
01:11 ET20011.415
01:13 ET53811.42
01:20 ET10011.405
01:22 ET20611.4081
01:24 ET10011.4
01:26 ET62811.4
01:29 ET30011.4
01:31 ET50111.42
01:33 ET64811.48
01:36 ET10011.485
01:38 ET20011.495
01:40 ET95011.5
01:42 ET30011.51
01:44 ET10011.5
01:45 ET20011.5
01:47 ET116511.465
01:49 ET10011.48
01:54 ET70011.47
01:56 ET90011.5
01:58 ET176811.56
02:00 ET165811.585
02:02 ET50011.61
02:03 ET197511.6266
02:05 ET20011.65
02:07 ET60011.62
02:09 ET30011.64
02:12 ET50011.64
02:14 ET90011.64
02:16 ET98911.64
02:18 ET138511.665
02:20 ET187811.67
02:21 ET120011.65
02:23 ET50011.65
02:25 ET70011.67
02:27 ET30011.665
02:30 ET20011.67
02:32 ET60011.65
02:34 ET10011.65
02:36 ET60011.655
02:38 ET40011.65
02:39 ET69011.67
02:41 ET50011.679
02:43 ET30011.685
02:48 ET70011.69
02:50 ET50011.69
02:52 ET55011.71
02:54 ET36711.72
02:56 ET20011.7
02:57 ET78511.69
02:59 ET90011.71
03:03 ET80011.74
03:06 ET110011.75
03:08 ET130011.7277
03:10 ET40011.76
03:12 ET40011.75
03:14 ET30011.74
03:15 ET20011.76
03:17 ET110011.735
03:19 ET115011.69
03:24 ET603311.67
03:26 ET67111.68
03:28 ET20011.65
03:30 ET110011.67
03:32 ET188811.72
03:33 ET86111.7
03:35 ET70011.69
03:37 ET176211.69
03:39 ET106411.675
03:42 ET53811.68
03:44 ET1397611.735
03:46 ET40011.735
03:48 ET80011.75
03:50 ET271111.765
03:51 ET347311.83
03:53 ET70011.85
03:55 ET240011.835
03:57 ET314011.81
04:00 ET597411.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCARA
Cara Therapeutics Inc
592.1M
-7.1x
---
United StatesCGEM
Cullinan Oncology Inc
560.7M
5.7x
---
United StatesNRIX
Nurix Therapeutics Inc
552.1M
-3.3x
---
United StatesRAPT
Rapt Therapeutics Inc
589.7M
-6.9x
---
United StatesATAI
ATAI Life Sciences NV
524.2M
-2.7x
---
United StatesRNA
Avidity Biosciences Inc
629.0M
-3.6x
---
As of 2022-11-30

Company Information

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates. The Company also initiated a pharmacokinetic safety trial of multiple doses of Oral CR845 in hemodialysis patients to define bioequivalent tablet strengths to inform its ability to develop an oral tablet formulation for moderate-to-severe uremic pruritus. CR701 is a peripherally restricted, mixed-CB1/CB2 receptor agonist that selectively interacts with these cannabinoid receptor subtypes, with no off-target activities.

Contact Information

Headquarters
4 Stamford Plaza 107 Elm Street 9Th FloorSTAMFORD, CT, United States 06902
Phone
203-406-3700
Fax
203-567-1510

Executives

President, Chief Executive Officer, Director
Christopher Posner
Chief Financial Officer
Ryan Maynard
Senior Vice President - Research and Development, Chief Scientific Officer
Frederique Menzaghi
Chief Compliance Officer, General Counsel, Secretary
Scott Terrillion
Chief Medical Officer
Joana Goncalves

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$592.1M
Revenue (TTM)
$39.4M
Shares Outstanding
53.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.94
EPS
$-1.66
Book Value
$4.25
P/E Ratio
-7.1x
Price/Sales (TTM)
15.0
Price/Cash Flow (TTM)
---
Operating Margin
-227.64%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.